Mutations in copper-zinc superoxide dismutase (SOD1) have been linked to a subset of familial amytrophic lateral sclerosis (fALS), a fatal neurodegenerative disease characterized by progressive motor neuron death. An increasing amount of evidence supports that mitochondrial dysfunction and apoptosis activation play a critical role in the fALS etiology, but little is known about the mechanisms by which SOD1 mutants cause the mitochondrial dysfunction and apoptosis. In this study, we use proteomic approaches to identify the mitochondrial proteins that are altered in the presence of a fALS-causing mutant G93A-SOD1. A comprehensive characterization of mitochondrial proteins from NSC34 cells, a motor neuron-like cell line, was achieved by two independent proteomic approaches. Four hundred seventy unique proteins were identified in the mitochondrial fraction collectively, 75 of which are newly discovered proteins that previously had only been reported at the cDNA level. Two-dimensional gel electrophoresis was subsequently used to analyze the differences between the mitochondrial proteomes of NSC34 cells expressing wild-type and G93A-SOD1. Nine and 36 protein spots displayed elevated and suppressed abundance respectively in G93A-SOD1-expressing cells. The 45 spots were identified by MS, and they include proteins involved in mitochondrial membrane transport, apoptosis, the respiratory chain, and molecular chaperones. In particular, alterations in the post-translational modifications of voltage-dependent anion channel 2 (VDAC2) were found, and its relevance to regulating mitochondrial membrane permeability and activation of apoptotic pathways is discussed. The potential role of other proteins in the mutant SOD1-mediated fALS is also discussed. This study has produced a short list of mitochondrial proteins that may hold the key to the mechanisms by which SOD1 mutants cause mitochondrial dysfunction and neuronal death. 
Amyotrophic lateral sclerosis (ALS)
1 is a fatal neurodegenerative disease characterized by progressive motor neuron death. Approximately 10% of ALS patients are familial cases (fALS), and mutations in the gene encoding copper-zinc superoxide dismutase (SOD1) were linked with a subset of fALS (1, 2) . To date, more than 90 mutations in SOD1 are known to be responsible for ϳ25% of fALS (3), most of which are point mutations that are scattered throughout the primary sequence and structure of the protein. There has been intensive research focusing on the etiology of SOD1 mutant-mediated fALS (see reviews in Refs. 4 -8) . It has been demonstrated that SOD1-null mice did not develop the disease (9) . In addition, transgenic mice expressing the ALS-associated mutants G93A-SOD1 (10, 11), G37R-SOD1 (12) , and G85R-SOD1 (13, 14) as well as transgenic rats expressing G93A-SOD1 (15, 16) and H46R-SOD1 (16) developed progressive motor neuron disease despite normal or elevated SOD1 activity. Therefore, it is believed that the ALS-linked mutants of SOD1 have acquired unknown toxic properties that eventually lead to the disease. However, the nature of the toxic "gain-of-function" of SOD1 mutations remains incompletely understood. It is neither understood what the downstream target of the toxicity associated with SOD1 mutants is, nor the mechanism by which the toxicity leads to motor neuron degeneration.
There are several hypotheses regarding the consequence of the toxic "gain-of-function" of mutant SOD1 and the mechanisms by which motor neurons die. They include mitochondrial dysfunction and activation of apoptosis (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) , SOD1 mutant-induced protein aggregation and its cytotoxicity (29 -31) , glutamate transporter EAAT2-mediated excitotoxicity (15, (32) (33) (34) , Fas-trigger FADD/caspase-8 apoptotic cascade activation (35) , and abnormal axonal transport caused by microfilament accumulation (36 -40) . This study focuses on the mitochondrial dysfunction/apoptosis hypothesis and searches for mitochondrial proteins that are altered by SOD1 mutants, i.e. the potential targets of the toxicity associated with SOD1 mutants.
Mitochondria play a vital role in the cell and mitochondrial dysfunction is likely to cause cell death. In ALS-transgenic mice, degeneration of mitochondria was observed prior to disease onset (10 -12, 20) . Other alterations in mitochondrial properties were also observed, such as vacuolation (11) , decreased activity of respiratory complexes II and IV (21, 22) , and loss of mitochondrial membrane potential (19) . SOD1, which is traditionally regarded as a cytosolic protein, was recently shown to be partially localized in the mitochondrial intermembrane space in yeast (41) , rat liver (42) , mouse neuroblastoma N2a cells (43) , and spinal cord neurons of G93A-SOD1 mice (44, 45) . Therefore, mitochondria could be directly involved in the mutant SOD1-mediated motor neuron death.
There has been increasing evidence that mitochondria-mediated apoptosis is involved in motor neuron degeneration. In ALS patients, pro-apoptotic proteins Bax (46) and Par4 (47) were observed to increase. In G93A-SOD1 mice, cytosolic release of cytochrome c was observed, and expression levels of pro-apoptotic proteins Bad and Bax were increased while those of anti-apoptotic proteins Bcl2, Bcl-xL, and XIAP were decreased (24, 48) . Caspase-1 and caspase-3 were sequentially activated in motor neurons and astrocytes in G93A-SOD1 mice as well as in G37R-SOD1 and G85R-SOD1 mice (25) (26) (27) . Another study showed that the mitochondrial localization of SOD1 mutants triggered the release of cytochrome c and activation of the caspase cascade (49) . A recent study showed that SOD1 interacted directly with Bcl2 and the highmolecular-weight complexes of mutant SOD1-bound Bcl2 in mitochondria from spinal cord (50) . Three strategies intervening in mitochondria-mediated apoptosis were demonstrated to be effective in delaying disease onset and progression in G93A-SOD1 mice: i) intraparitoneal administration of minocycline, which inhibits mitochondrial permeability-transition-mediated cytochrome c release, was shown to delay disease onset and extend survival (28) ; ii) overexpression of Bcl2, which can rescue motor neurons from apoptotic death during early development (51) , could delay activation of the caspases, attenuate neuron degeneration, and delay disease onset and mortality (18, 23) ; and iii) intraventricular administration of N-benzyloxycarbonyl-Val-Asp-fluoromethylketone (zVAD-fmk, a broad spectrum caspase inhibitor) could delay disease onset and mortality (25) . It should be noted that apoptosis activation in ALS mice was observed months prior to the disease onset. This suggests that at least in mutant SOD1-mediated familial ALS, apoptosis is not a secondary phenomenon leading to the final degeneration of motor neurons. The chronic progression of apoptosis might be enhanced by an age-related increase of oxidative stress and/or aberrant pro-oxidative properties of mutant SOD1. It remains largely unclear what factor(s) initiate the mitochondrial dysfunction and apoptosis in ALS.
In this study, we have used unbiased proteomic approaches to characterize changes in the mitochondrial proteome in the presence of mutant SOD1. We have established a cell line model of fALS by overexpressing SOD1 mutants in NSC34 cells, a mouse embryonic spinal cord neuron-neuroblastoma hybrid cell line that has many features of motor neurons. We have surveyed the mitochondrial proteome of the mouse model motor neurons and report 75 mitochondrial proteins that previously were only reported at the gene level. We have also compared the mitochondrial proteomes of NSC34 cells expressing wild-type (WT) and G93A-SOD1, respectively, and have found an array of proteins that are altered in the presence of G93A-SOD1. The relevance of these altered proteins in mitochondrial dysfunction/apoptosis and motor neuron death is discussed.
EXPERIMENTAL PROCEDURES
Reagents-IPG strips and appropriate IPG buffers were purchased from Amersham Biosciences (Piscataway, NJ). Acrylamide (40%, 29:1) was purchased from Bio-Rad (Hercules, CA). Trypsin (modified, sequencing grade, lypholized) was purchased from Promega (Madison, WI). Protease inhibitor mixture, CHAPS, and DTT were purchased from Sigma (St. Louis, MO). Other commonly used reagents were purchased from Fisher Scientific (Hampton, NJ) unless otherwise indicated.
Establishment of the Cell Line Model of fALS-The cDNAs encoding human WT and G93A-SOD1 in YEp351 yeast expression vector were a generous gift from Joan S. Valentine (University of California Los Angeles, Los Angeles, CA). The SOD1-encoding sequences were amplified by PCR using the following two primers containing BamHI and EcoRI endonuclease restriction enzyme sites: 5Ј-GCGAATTCC-ATGGCGACGAAG-3Ј and 5Ј-GCGGATCCTTATTGGGCGATCCCAA-TTAC-3Ј. The amplified human WT-and G93A-SOD1 genes were then subcloned into the mammalian expression vector pIRESneo3 (Clontech, Palo Alto, CA), and the sequence fidelity was verified by DNA sequencing. The pIRESneo3 vector uses the cytomegalovirus promoter to control the transcription of a single mRNA containing the human SOD1-encoding sequence, the internal ribosome entry site (IRES) of the encephalomyocarditis virus and the neomycin selection marker in tandem. The advantage of this vector is that SOD1 and neomycin will be translated from one mRNA, thus nearly 100% of cells that survived neomycin selection will express SOD1. In addition, different concentrations of neomycin can select cells with different SOD1 expression levels. NSC34, a mouse embryonic spinal cord-neuroblastoma cell line with a motor neuron phenotype (52, 53) , was used as an in vitro model system to carry out this proteomic study. Cells were cultured at 37°C under 5% CO 2 -95% air in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine albumin, 100 g/ml streptomycin sulfate, and 100 U/ml penicillin (22, 52, 53) . Eighty percent confluent NSC34 cells in a six-well plate were transfected with the pIRES-WT-SOD1 and pIRES-G93A-SOD1 plasmids, respectively, using the Lipofectamine protocol (Invitrogen, Carlsbad, CA). Two days after transfection, cells were transferred into a 10-cm cell culture disk and treated with 200 g/ml neomycin for 4 wk. Medium containing 200 g/ml neomycin was changed every 4 days during the selection period. Ten to 20 clones that survived the neomycin selection were pooled together and named NSC34
WT-SOD1 and NSC34 G93A-SOD1 , respectively. The expression levels of human SOD1 were examined by Western blotting with SOD1 polyclonal antibody (Santa Cruz Biotechnology, Santa Cruz, CA).
Purification of Mitochondria from NSC34 Cells-Mitochondria purification was performed as previously described (41, 43) with slight modifications. Briefly, NSC34
WT-SOD1 and NSC34 G93A-SOD1 cells from four confluent 10-cm plates (ϳ2 ϫ 10 6 cells/plate) were collected and washed with ice-cold PBS. The cell pellet was resuspended in 1.8 ml of cell homogenizing medium (CHM; 10 mM Tris-Cl, 150 mM MgCl 2 , 10 mM KCl, 1 mM DTT, and 1% protease inhibitor mixture, pH 6.7, and homogenized with 20 strokes of the dauncer followed by adding 0.6 ml of CHM with 1 M sucrose. The homogenate was centrifuged at 1,000 ϫ g for 5 min to remove the nucleus, plasma membrane, and unbroken cells, and this step was repeated twice. The crude mitochondrial fraction was collected from the supernatant by centrifugation at 5,000 ϫ g for 10 min. The pellet was washed once with 1 ml of sucrose/Mg buffer (10 mM Tris-Cl, 0.15 M MgCl 2 , 0.25 M sucrose, 1 mM DTT, and 1% protease inhibitor mixture, pH 6.7) and resuspended with 300 l of mannitol buffer A (5 mM HEPES, 0.25 M mannitol, 0.5 mM EGTA, 0.1% BSA, 1 mM DTT, and 1% protease inhibitor mixture, pH 7.4). Resuspended mitochondria were layered onto 3.5-ml 30% Percoll solution (30% Percoll, 25 mM HEPES, 225 mM mannitol, 1 mM EGTA, 1 mM DTT, and 1% protease inhibitor mixture, 0.1% BSA, 1 mM DTT, and 1% protease inhibitor mixture, pH 7.4) followed by centrifugation at 95,000 ϫ g for 30 min. Approximately 400 l of the cloudy fraction was collected and diluted with 1 ml of mannitol buffer A followed by centrifugation at 6,400 ϫ g for 10 min. The pellet was washed three times with 1 ml of mitochondrial washing buffer (10 mM HEPES, 220 mM mannitol, 68 mM sucrose, 10 mM KCl, 1 mM EGTA, 1 mM DTT, and 1% protease inhibitor mixture, pH 7.4) and stocked at Ϫ80°C until use.
Gel Electrophoresis of Mitochondrial Proteins-Mitochondria were subjected to both one-dimensional SDS-PAGE and two-dimensional (2D) electrophoresis. For one-dimensional gel electrophoresis, the mitochondrial pellet was resuspended and homogenized in SDS-PAGE sample buffer (ϳ100 g of protein in 40 l of buffer) and centrifuged at 10,000 ϫ g for 5 min. The supernatant was applied to 12% SDS-PAGE followed by Sypro Ruby staining.
Two-dimensional gel electrophoresis of the mitochondrial fraction isolated from NSC34
WT-SOD1 and NSC34 G93A-SOD1 cells was carried out as previously described (54) . Briefly, the mitochondrial pellet was resuspended and homogenized in rehydration buffer (8 M urea, 2% CHAPS, 0.5% IPG buffer 3-10) (ϳ100 to 150 g of protein in 50 l of buffer) and centrifuged at 10,000 ϫ g for 5 min. The supernatant was applied to 18-cm IPG strips (pI range 3-10) through the sample loading cup located at the anode end of the strips and focused using the IPGphor protein IEF apparatus for 100,000 Vh. The strips were equilibrated and subjected to the second dimension of 12% SDSpolyacrylamide gels followed by Sypro Ruby staining. Gel images were acquired by a Storm fluorescence scanner (Amersham Pharmacia Biotech).
Analysis of the Images of 2D Electrophoresis-Two-dimensional gel images were analyzed by PDQuest software (Bio-Rad) to compare the 2D gels of the NSC34
WT-SOD1 and NSC34 G93A-SOD1 . Spot detection and matching between six gels (three from NSC34
WT-SOD1 and three from NSC34 G93A-SOD1 ) were performed automatically, followed by manual matching. After normalization of the spot densities against the whole-gel densities, statistical analysis was performed by independent Student t test. The p values of the intensity changes of each spot among three independent experiments were calculated. The protein spots with p values less than 0.05 were considered as those displaying significant changes between NSC34
WT-SOD1 and NSC34
G93A-SOD1 cells. Protein Digestion and MS Analysis-After SDS-PAGE of the mitochondrial proteins, 20 protein bands of equivalent size were sliced from the gel. After 2D gel electrophoresis of the mitochondrial proteins, 480 protein spots of greatest density were excised from the gel. All gel bands or pieces were washed and digested with trypsin as previously described (54, 55) . The resulting peptides were extracted using 50 l of 0.02% heptafluorobutylic acid (HFBA) and 50 l of 0.02% HFBA/50% ACN and concentrated to 10 l with a Speed Vac.
The peptides from one-dimensional SDS-PAGE were subjected to LC-MS/MS analysis. Each sample was loaded to a C18 reversephase capillary column (75 m ϫ 15 cm) and eluted using a linear 1-h gradient running from 5 to 60% ACN. Peptides eluted from the column were directly sprayed into the Qstar XL Q-TOF mass spectrometer (Applied Biosystems, Foster City, CA) through a nano-electrospray source. The Qstar XL was operated in the information-dependent acquisition mode, first measuring the masses of the eluted peptides then automatically selecting the three most abundant peptide ions to perform MS/MS to obtain the sequence information. Peptides from 2D electrophoresis were desalted by Zip-tip (Millipore, Billerica, MA), spotted to MALDI plates, and analyzed by Qstar XL with the MALDI source. Both MS of all peptides and MS/MS spectra of four most abundant peptides in each sample were recorded by Qstar XL and subsequently used for protein identification.
Protein Identification and Data Analysis-The above MALDI-MS, MALDI-MS/MS, and LC-MS/MS data were all subjected to database searches for protein identification using a local MASCOT search engine (56) . Multiple databases, NCBInr, Swiss-Prot, and MSDB, were searched to yield more comprehensive and complementary results. The MALDI-MS data were submitted to the MASCOT server for peptide mass fingerprint (PMF) search. The peak lists from the MALDI-MS spectra were first generated by MASCOT Wizard using the following parameters: no smoothing, signal-to-noise ratio is great than 5, and baseline is correlated by the MASCOT algorithm. The peak lists were subsequently submitted for PMF search using the following parameters: Mus musculus, maximum of one trypsin miscleavage, cysteine carbamiodomethylation, methionine oxidation, and a maximum of 100 ppm MS error tolerance. For each PMF search, a probability score is calculated by the MASCOT algorithm and is required to be higher than 62 (i.e. p Ͻ 0.05). In addition, a minimum of three matching peptides are required for positive protein identification.
The MALDI-MS/MS and LC-MS/MS data were submitted to the MASCOT server for MS/MS ion search. The peak lists from the LC-MS/MS spectra were generated by the MASCOT script embedded in the Analyst QS software using the following parameters: no smoothing, charge state determined from the MS scan, precursor ion charge states of 2ϩ and 3ϩ, centroid MS/MS data, height percentage 50%, and merge distance 0.02 Da. The peak lists from the MALDI-MS/MS spectra were generated using the same parameters except using precursor ion charge states of 1ϩ. The typical parameters used in the MASCOT MS/MS ion search are: Mus musculus, maximum of one trypsin miscleavage, cysteine carbamiodomethylation, methionine oxidation, a maximum of 100 ppm MS error tolerance, and a maximum of 0.2 Da MS/MS error tolerance. For MS/MS ion search, proteins with one peptide ion scoring higher than 45 or two peptide ions scoring higher than 30 were considered an unambiguous identification without manual inspection. All other hits were manually verified by confirming the peptide sequences from the MS/MS spectra.
RESULTS

A Cellular Model of fALS-NSC34 cells stably transfected with cDNAs of human WT-and G93A-SOD1 (designated as NSC34
WT-SOD1 and NSC34 G93A-SOD1 , respectively) were generated as described in "Experimental Procedures." The expression levels of SOD1 proteins were assessed by Western blotting analysis using a polyclonal antibody against both human and mouse SOD1 as shown in Fig. 1 . Significant levels of human WT-and G93A-SOD1 were expressed in the stable pools. The expression levels of human SOD1 were less than the endogenous mouse SOD1, thus artifacts associated with overexpression of exogenous proteins are not a concern in these clones. Furthermore, the NSC34 G93A-SOD1 cells were more susceptible to oxidative stress than the NSC34
WT-SOD1 cells. Protein aggregates containing SOD1 were also observed in the NSC34 G93A-SOD1 cells. A more detailed description of this cellular model of ALS will be described elsewhere (Zhang and Zhu, unpublished results).
Protein Identification from 2D Gel Electrophoresis Followed by MALDI-MS and MALDI-MS/MS Analysis-Mitochondrial
proteins were separated by 2D gel electrophoresis to ϳ600 protein spots that were recognized by the PDQuest software WT-SOD1 and NSC34
G93A-SOD1 cells was resolved by 12% SDS-PAGE, transferred to a nitrocellulous membrane, and blotted with an SOD1 polyclonal antibody. The endogenous mouse SOD1 and human SOD1 are indicated by arrows. Significant levels of human WT-and G93A-SOD1 are expressed in NSC34 and NSC34
G93A-SOD1 cells, respectively.
FIG. 2. A representative 2D gel electrophoresis image of the mitochondrial fraction isolated from NSC34
WT-SOD1 cells. The gel was stained by Sypro Ruby, and the image was acquired using a Storm fluorescence scanner. PDQuest software was used to analyze the image and assign the protein spots. Two hundred forty proteins spots that have been identified are indexed as numbered, and the complete list of proteins is in the supplemental table.
( Fig. 2) . Recent proteomic studies of mitochondria isolated from several tissues/organisms have reported 400 -600 proteins (57, 58) , similar to the number of protein spots in this study. Approximately 480 spots were excised from a 2D gel, while about 120 spots with extremely faint densities were omitted. In-gel tryptic digestion was performed, and the extracted tryptic peptides were analyzed by MALDI-MS/MS in an automated fashion. Database searching with both PMF and MS/MS spectra was also performed using the MASCOT algorithm to search the NCBInr database. In the case that a protein was not identified using the NCBInr database, the Swiss-Prot and MSDB databases were used and positive protein identification was achieved. The protein identification was positive when the following two criteria were met: 1) a probability score calculated by MASCOT is higher than 62, i.e. the probability of the random match is less than 0.05; 2) a minimum of three matching peptides are present. In addition, we took advantage of the MALDI-MS/MS capability of the Qstar XL mass spectrometer and acquired MS/MS data from the four most abundant ions. The MALDI-MS/MS data were submitted for MS/MS ion search using the parameters and criteria described in "Experimental Procedures." In most cases, both PMF and MS/MS ion searches yielded identical protein identification results. In a few cases in which the scores of both PMF and MS/MS database searches were marginally lower than the threshold, the MS/MS spectra were manually examined to confirm the peptide sequences. Out of the 480 spots analyzed, 240 spots were positively identified. The identification rate of all 480 protein spots was ϳ50%, but the identification rate of ϳ200 protein spots with higher than moderate intensity was more than 90%. The 170 unique proteins that were identified from the 240 2D gel spots are listed in the supplemental table.
With a few exceptions, the positions of the protein spots in the 2D gel electrophoresis were well correlated with the theoretical values of molecular weight and pI values of the identified proteins. In the few exceptions, the protein spots might be post-translational modification products, other adducts, or degradation products of the identified proteins. It is also noted that 38 unique proteins have multiple isoforms as each of them are represented by more than two distinct 2D gel spots. For instance, 10 different 2D gel spots (spots 184, 186, 187, 188, 189, 205, 207, 221, 229, and 230 in Fig. 2 ) were all identified as ATP synthase mitochondrial F 1 complex ␣ subunit isoform 1. These spots possibly represent the post-translational modification products of the protein. This is also the reason that 170 unique proteins were identified from 240 2D gel spots.
Protein Identification from SDS-PAGE Followed by Nano-LC-MS/MS Analysis-More than 500 MS/MS spectra were obtained from the LC-MS/MS experiment of each gel band excised from the SDS-PAGE of mitochondrial proteins. The LC-MS/MS data were subsequently subjected to MASCOT MS/MS ion search using the parameters described in "Experimental Procedures." Proteins with one peptide ion scoring higher than 45 or two peptide ions scoring higher than 30 were considered unambiguous identification without manual inspection. All other hits were manually verified by confirming the peptide sequences from the MS/MS spectra. A total of 387 unique proteins were identified from the 20 gel bands of mitochondrial proteins, which are listed in the supplemental table.
The two independent approaches, 2D gel followed by MALDI-MS/MS and SDS-PAGE followed by LC-MS/MS, have identified 170 and 387 unique proteins, respectively, as illustrated in Fig. 3 . Of these proteins, 87 proteins were commonly identified in both approaches. Eighty-three and 300 proteins were uniquely identified in the 2D gel and SDS-PAGE approach, respectively. Collectively, 470 unique proteins were identified from the mitochondrial fraction of NSC34 cells. (36%) are well-characterized mitochondrial proteins, 44 proteins (9%) are shown to localize in endoplasmic reticulum (ER) and 43 proteins (9%) are cytoskeleton and related proteins. ER and cytoskeleton are commonly found to be associated with mitochondria during isolation. Sixty-nine (15%), 43 (9%), 20 (4%), 18 (4%), 6 (1%), and 1 (0.2%) proteins were shown to localize in the cytosol, membrane fraction (including plasma membrane), cytosolic ribosome, protein trafficking vesicles, nucleus, and proteasome, respectively. No subcellular localization information was available for the remaining 54 (12%) proteins. For the proteins that are reported to be localized in other subcellular compartments, it is likely that they are localized in mitochondria or associated with the mitochondrial membrane in NSC34 cells. Alternatively, they may be contaminants from the mitochondrial purification process. We have not distinguished these two possibilities.
Newly Identified Mitochondrial Proteins-Seventy-five new proteins, which were previously reported as cDNAs, have been identified in the mitochondrial fraction of NSC34 cells. All 75 proteins were submitted to the BLAST sequence similarity search against proteins from other organisms in NCBI protein database. Out of these proteins, 47 (63%) proteins display high sequence homology to the proteins of mouse or the other organisms that have been annotated in the EXPASY or Proteome BioKnowledge databases. Twenty-three (31%) proteins have sequence homology to less-characterized proteins while five (7%) proteins have no homolog to any proteins from any organisms. The 75 newly identified proteins are listed in Table I .
Out of the 47 new proteins that have sequence similarities to other annotated proteins, 18 (38%) proteins are known to be localized in mitochondria. Three (6%) and two (4%) proteins are homologous to proteins associated with cytoskeleton and ER, respectively. The subcellular localization information for 16 (34%) other proteins was not found.
Function of the Identified Proteins-The functions of the 171 mitochondrial proteins that have been annotated in either EXPASY or Proteome BioKnowledge databases are illustrated in Fig. 4 . The largest percentage of proteins (92 proteins, 54%) are those with catalytic activities related to metabolism and energy production. More than half of the metabolic proteins are enzymes involved in the TCA cycle or the mitochon- 
Differentially Expressed Proteins in Mitochondria of NSC34
WT-SOD1 and NSC34 G93A-SOD1 -Mitochondrial dysfunction and apoptosis have been demonstrated in fALS but the mechanisms by which SOD1 mutations cause these mitochondrial abnormalities are not clear. After surveying the mitochondrial proteome of NSC34 cells, we used the 2D gel electrophoresis approach to examine the differentially expressed mitochondrial proteins between NSC34 cells expressing WT and G93A mutant SOD1. The mitochondrial fractions were isolated from NSC34
WT-SOD1 to NSC34
G93A-SOD1 cells, respectively, and subjected to 2D gel electrophoresis as described earlier. The mitochondrial protein expression profiles of NSC34 WT-SOD1 to NSC34 G93A-SOD1 cells were analyzed by PDQuest software. The density of each spot was determined by the software and normalized against the total gel density that represents the total protein quantity in the mitochondrial fraction. The experiment was carried out three times independently, and the Student t test was performed to determine the statistically significant alterations. Nine and 36 protein spots were found to have increased and decreased abundance, respectively, in NSC34
G93A-SOD1 cells compared with those in NSC34
WT-SOD1 cells. The p values for these spots in three independent experiments were less than 0.05. The 45 protein spots that display altered abundances are shown in Table II , and representative images of two such spots are shown in Fig. 5 .
As noted earlier, post-translational modification occurs in many mitochondrial proteins, resulting in the fact that multiple proteins spots in the 2D gel are identified as the same protein. Table  II, 24 spots were identified to be 19 unique proteins that have multiple spots in 2D gel. In other words, more than half of the protein spots that are changed in the mitochondria of NSC34 G93A-SOD1 cells are those representing protein posttranslational modification isoforms. The results suggest that the fALS mutant G93A-SOD1 often causes alterations in protein post-translational modifications.
Out of 45 differentially expressed protein spots listed in
Functions of the proteins in Table II , which are changed in the presence of G93A-SOD1 in NSC34 cells, are related to many essential cellular functions as shown in Fig. 6 . Half of them have the metabolic functions, mainly involved in the mitochondrial respiratory chain including the subunits of complex I, III, IV, and V. Heat shock proteins/molecular chaperones were also identified from five spots consisting of 11% of the total proteins altered: chaperonin subunit 5 (⑀), chaperonin subunit 6a (), DnaJ (Hsp40) homolog subfamily B member 11, and two spots of heat shock 70-kDa protein 5. It is noted that all molecular chaperone proteins displayed decreased abundances in NSC34 G93A-SOD1 . Mitochondrial membrane proteins, voltage-dependent anion channel 1 (VDAC1) and VDAC2, are affected by G93A-SOD1 as well. VDACs are components of mitochondrial membrane permeability transition pore and are known to regulate the mitochondrial membrane permeability and the cytochrome c release from mitochondria. The modification isoforms of VDAC1 and VDAC2 showed decreased levels in NSC34 G93A-SOD1 cells, which may lead to deregulation of cytochrome c release and activation of apoptosis. The significance of the alterations in these proteins will be discussed, and this study will lay ground for further studies.
DISCUSSION
Despite increasing evidence suggesting that mitochondrial dysfunction and apoptosis play a role in the pathogenesis of mutant SOD1-mediated fALS, little is known about the mechanisms by which mutant SOD1 causes mitochondrial dysfunction in motor neurons that are specifically damaged in the disease. A comprehensive analysis of the mitochondrial protein expression profile in the presence and absence of fALSlinked SOD1 mutant can provide important insight into the role of mitochondria in the disease. We have used two independent approaches, 2D gel electrophoresis followed by MALDI-MS/MS and SDS-PAGE followed by LC-MS/MS, to characterize the mitochondrial proteome of motor neuron-like NSC34 cells as well as the alterations in the mitochondrial proteome in the presence of fALS-linked mutant G93A-SOD1.
The first achievement of this study is the comprehensive survey of mitochondrial proteins in NSC34 cells, a mouse embryonic spinal cord-neuroblastoma hybrid cell line. Transgenic mice are powerful tools in biomedical research, providing animal models for many diseases. The identification of mitochondrial proteins in mouse neuronal cells is not only essential to the comparative analysis in this study but also invaluable to the scientific community, particularly those studying the role of mitochondria in various diseases using mice as animal models.
Two-dimensional gel electrophoresis separation of the isolated mitochondrial fraction of NSC34 cells yielded ϳ600 protein spots, which is close to the number of mitochondrial proteins isolated from the human heart and other sources (52, 53) . Subsequent MALDI-MS/MS analysis identified 170 Table I . Though this study is not designed to study the functions of these novel mouse mitochondrial proteins, which need to be further investigated by other groups in the field, it provides initial evidence that these genes are expressed in mouse neuronal cells and isolated in the mitochondrial fraction. The functions of the mitochondrial proteins that have been annotated in the EXPASY and Proteome BioKnowledge databases include metabolism (TCA cycle, respiratory chain, amino acid metabolism, lipid metabolism, etc.), membrane transport, mitochondrial ribosome, heat shock/molecular chaperone, redox, and antioxidant proteins, among others. This finding is consistent with the fact that the mitochondrion is the main organelle responsible for energy generation.
Many identified proteins in this study are well-characterized mitochondrial proteins as noted in two annotated protein databases, EXPASY and Proteome BioKnowledge. Other proteins are not annotated as mitochondrial proteins in the above two databases. Most of those are known as ER and nucleus proteins. We used the Percoll gradient ultracentrifugation technique to isolate the mitochondrial fraction, which is widely recognized as the technique producing least contamination. However, it remains possible that other proteins, particularly ER proteins, may be co-localized in the mitochondrial fraction as contaminants. It is also possible that some of the "contaminating" proteins are partially localized in mitochondria or interact with other mitochondrial proteins. More detailed studies such as immuno-colocalization experiments are needed to distinguish these different possibilities, which are beyond the scope of this study.
To better understand the mechanisms underlying mitochondrial dysfunction in mutant SOD1-mediated fALS, the mitochondrial proteomes from NSC34 and NSC34
G93A-SOD1 were compared by 2D gel electrophoresis in this study. Nine and 36 spots displayed increased and decreased levels, respectively. These 45 spots represent 40 distinct proteins. Out of the 40 unique proteins that displayed differential levels in the mitochondrial fractions, 27 proteins have been clearly described as mitochondrial proteins, such FIG. 5 . Representative 2D gel protein spots that displayed differential levels between NSC34
WT-SOD1 and NSC34 G93A-SOD1 cells. A, the protein named "Similar to septin6 type II" (spot 125 in Fig. 2 ) has increased abundance in NSC34
G93A-SOD1 cells (NSC34  G93A-SOD1 /  NSC34 WT-SOD1 ϭ 1.97, p ϭ 0.019). B, the protein "Heat shock 70-kDa protein 5" (spot 64 in Fig. 2 ) has decreased abundance in NSC34 G93A-SOD1 cells (NSC34 G93A-SOD1 /NSC34 WT-SOD1 ϭ 0.58, p ϭ 0.038). Forty-five 2D gel spots display altered abundance between the mitochondrial fractions isolated from NSC34
G93A-SOD1 cells. These 45 protein spots were identified as 40 unique proteins, and they are listed in Table II Table I ). For example, RIKEN cDNA 4430402G14 has 96% sequence similarity to rat Ubiquinolcytochrome c reductase Rieske iron-sulfur polypeptide. Twenty-four of 45 2D gel spots that displayed differential abundances are proteins that have multiple 2D gel spots, suggesting that G93A-SOD1 often causes alterations in protein post-translational modifications. Modifications in a particular protein named VDAC2 is discussed below. It is worth noting that an advantage of the 2D gel electrophoresis approach is its ability of detecting such differences in the modification states of a protein.
The main hypothesis driving this study is that the mitochondrial dysfunction and activation of apoptosis play a role in the motor neuron death in fALS, which has been supported by various results from different laboratories. One of the differentially expressed protein spots we have identified is a mitochondrial outer membrane protein named VDAC2 (see Table  II ). VDAC2 is one of three mammalian VDACs and shows 75 and 73% sequence identity to VDAC1 and VDAC3, respectively. VDACs are mitochondrial outer membrane proteins that can form membrane permeability transition pores, and their common functions are to control ADP translocation into mitochondria and the mitochondrial outer membrane potential (59, 60) . Thus, VDAC2 could be directly involved in abnormal mitochondrial morphology observed in the ALS-transgenic mice. It is well documented that VDAC1 is involved in apoptosis activation by interacting with bcl-2 family members (60 -63) . VDAC2 is recently reported to be a specific inhibitor of BAK-dependent mitochondrial apoptosis by interacting with the inactive form of BAK and preventing BAK from being activated (64) . Consequently, VDAC2 deficiency is lethal to mouse embryos (64) . Thus, it is reasonable to speculate that VDAC2 can be directly involved in regulating apoptosis as has been implicated in the ALS etiology.
We observed two lines of evidence supporting the potential role of VDAC2 in ALS (1). Five distinct 2D gel spots (spots 152, 157, 158, 164, and 165 in Fig. 2 ) with the same molecular mass (ϳ33 kDa) but different pI values (ranging from 4 to 8) were all identified as VDAC2. Equivalent molecular mass of the five spots suggests that they are not likely to be different splicing products. Rather, the 2D gel pattern suggests that they are modified isoforms of VDAC2. The nature of the modification has not been determined in this study yet, but is speculated to phosphorylation or oxidation, which can change the pI values (2) . The abundance of one particular isoform (spot 164) decreased ϳ2-fold in NSC34
G93A-SOD1 cells compared with that in NSC34
WT-SOD1 , while other spots (spots 152, 157, 158, and 165) were not significantly changed. Little is known about the post-translational modifications of VDAC2 or the mechanisms by which VDAC2 regulates apoptosis. It is not uncommon that specific modification events, particularly protein phosphorylation, can modulate protein function and signaling pathways. Thus, it is conceivable that the change in the specific modification state of VDAC2 is likely to be involved in mutant SOD1-mediated toxicity and the subsequent mitochondrial dysfunction and apoptosis activation. Future studies of VDAC2 modifications and its role in regulating apoptosis are necessary to elucidate its relevance to the pathogenesis of fALS.
In addition, it is noted that fALS is a complex disease and the SOD1 mutants may disturb other mitochondrial functions. Findings in this comprehensive proteomic study can explain several other observations in fALS. First, five heat shock proteins/chaperones, chaperonin subunit 5 (⑀), chaperonin subunit 6a (), DnaJ (Hsp40) homolog subfamily B member 11, and two spots of heat shock 70-kDa protein 5, were down-regulated in NSC34
G93A-SOD1 . It has been proposed that the availability of heat shock proteins (HSPs) is reduced by the misfolded and aggregated mutant SOD1 (8, 31) , leading to the compromised molecular chaperone activities and cellular damages. The levels of HSPs in motor neurons were shown to be lower than those in astrocytes (65) . Beneficial effects of elevated levels of HSPs were also demonstrated in cell line and transgenic mouse models (66, 67) . Moreover, HSPs should play a role in protein translocation into mitochondria because proteins need to be at least partially unfolded to pass through the mitochondrial membrane pore and subsequently need to refold. In fact, cytosolic HSPs were shown to partially block the mitochondrial entry of mutant SOD1 but not WT-SOD1 (43) . Recent studies showed that mutant SOD1 were present in mitochondria from motor neurons but WT SOD1 were not (45, 50) . We observed both WT and G93A-SOD1 in the mitochondrial fraction isolated from NSC34 cells by Western blotting (data not shown). We identified manganese SOD (SOD2, a typical mitochondrial matrix protein, see the supplemental table) but not SOD1 using the proteomic approaches in this study, probably because the level of SOD1 was below the detection limit of the approaches. Though little is known about the detailed mechanisms by which a fraction of SOD1 enters mitochondria, it is likely that mitochondrial HSPs can also affect the entry of mutant SOD1 into mitochondria, thus playing a role in the mutant SOD1-mediated mitochondrial abnormalities. Thus, the finding of this study, i.e. the decreased levels of mitochondrial HSPs in NSC34 cells, can be related with the entry of mutant SOD1 into mitochondria and the subsequent activation of apoptosis.
Second, half of the differentially expressed proteins are involved in various metabolic pathways, mainly the mitochondrial respiratory chain including the subunits of complex I, III, IV, and V. It was previously reported that the activity of com-plexes II and IV were suppressed in a similar cell line model of fALS (21, 22) . The findings of this study may underline the mechanisms of such suppressed respiratory activities.
The findings in this study provide comprehensive knowledge of the mitochondrial proteome in mouse neuronal cells, which has broad impact on the research of mitochondrial diseases using transgenic mouse models. This study has yielded a short list of mitochondrial proteins that may hold the key to the mechanisms by which SOD1 mutants cause abnormal mitochondrial morphology and apoptosis activation. It has laid ground for future detailed functional studies to elucidate the role of particular mitochondrial proteins, such as VDAC2, in the pathogenesis of fALS.
